Sr. Applied Research Engineer – Biomechanics – Burlington
What You’ll Do:
We are seeking a highly motivated and experienced scientist or engineer to join our Applied Research team and contribute to the advancement of next-generation technologies within our Corneal Health (CH) product portfolio. This role will play a central part in driving early-stage innovation, technology development, and translational research efforts aimed at expanding the capabilities and clinical impact of our ophthalmic medical device platforms.
The successful candidate will work at the intersection of computational modeling, experimental science, engineering, and clinical translation to develop new technologies and methodologies. A key focus of this role will be developing and validating computational and analytical models of corneal and tissue biomechanics, complemented by hands-on imaging and elastography work that enables improved understanding and quantification of corneal structure and biomechanics.
The ideal candidate will bring deep expertise in tissue and corneal biomechanics and computational modeling, complemented by hands-on experience with biomechanical imaging, elastography, signal processing, and algorithm design, with a strong interest in translating research concepts into robust, validated technologies.
How You’ll Contribute:
Contribute to the design and development of current and next-generation ophthalmic medical devices, from early research through translational development.
• Develop, apply, and validate analytical and computational models of corneal and ocular tissue biomechanics, including finite element approaches, to characterize tissue behavior and therapeutic effects.
Use experimental and imaging-derived data to estimate material properties, perform in-verse and parameter-estimation analyses, and validate model predictions.
• Support and perform biomechanical imaging and elastography measurements, including refinement of experimental setups used to quantify corneal biomechanical properties.
• Develop, optimize, and maintain robust modeling, processing, and post-processing algorithms and software pipelines for biomedical imaging and biomechanical data.
• Collaborate with hardware, software, and systems engineering teams to integrate models, algorithms, and experimental methods into prototype and product-level medical devices.
• Oversee data collection, preprocessing, model and algorithm development, validation, and performance characterization through rigorous experimental testing.
• Evaluate emerging modeling methods and measurement technologies to advance biomechanical characterization for ophthalmic applications.
• Communicate technical results through design reviews, internal reports, and technical documentation; contribute to publications, patents, or regulatory submissions as appropriate.
How You’ll Get There:
• PhD in Mechanical Engineering, Biomedical Engineering, Physics, or a related field, or an MS/Bachelor’s degree with equivalent industry experience.
• 5–8+ years of relevant experience (3–5+ years with an MS degree or 0–4+ years with a PhD) in soft-tissue biomechanics, computational modeling, experimental imaging, or quantitative analysis.
• Demonstrated experience developing and validating biomechanical models of soft tis-sues, including constitutive modeling, finite element analysis, and parameter estimation from experimental data.
• Working knowledge of biomechanical imaging and elastography, including measurement setups, data acquisition, and measurement system validation.
• Hands-on experience with finite element modeling tools; COMSOL Multiphysics experience is preferred.
#GKOSUS
Generous. Innovative. Leadership-driven. Family-oriented. Socially responsible.
Founded in 1998, Glaukos Corporation is an ophthalmic pharmaceutical and medical technology company focused on developing and commercializing novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases.
Our mission at Glaukos is to truly transform vision by pioneering novel, dropless therapies that can meaningfully advance the standard of care and improve the lives of patients suffering from chronic, sight-threatening eye diseases.
Innovation is at the core of everything we do, and we are resolute in our commitment to challenge conventional thinking with new treatment alternatives that are supported by real science, robust clinical evidence, and an unrelenting focus on patients.
Our constant pursuit of game-changing technologies that disrupt legacy treatment paradigms is encapsulated in the Glaukos mantra “We’ll Go First,” which articulates our willingness to take chances, our determination to forge new ground, and our commitment to continuous improvement in all that we do.
Our company completed an initial public offering in June of 2015, and our shares are traded on the New York Stock Exchange under the ticker symbol “GKOS”. Our global headquarters is in Aliso Viejo, California with additional locations in San Clemente, California, and Burlington, Massachusetts.
Glaukos Corporation is an Equal Opportunity/Affirmative Action Employer All qualified applicants will receive consideration for employment without regard to race, color, religion, sex including sexual orientation and gender identity, national origin, disability, protected Veteran Status, or any other characteristic protected by applicable federal, state, or local law.
All offers of employment are contingent upon the successful completion of a background check, including successfully passing a drug screen, based on the position and local regulations.
